Trending Now

Karma is a b…ch when every one hates Martin Shkreli

Popular Stories

couldn’t have happened to a nicer guy … he he he 
Ironically, patent rights was at the center of the Daraprim monopoly.

Pharma bro …When all your chickens start heading home to roost  
Martin Shkreli faces a new lawsuit claiming that his $2 million Wu-Tang Clan album contains illustrations ripped off from New York artist, Jason Koza, who now wants the former drug executive to pay for them
‘ Shkreli isn’t going to listen to album, but bought to ‘keep it from the people’ , and that is just piling on

Martin Shekreli 5Smirking Martin Shkreli, aka Pharma bro, [photo], CEO of  Turing Pharmaceuticals,  remember him?
He is now facing a  copyright suit involving one-off Wu-Tang Album he bought for $2m just to ‘keep from the people’  he faces lawsuit claiming that his $2 million Wu-Tang Clan album has artwork ripped off from NYC artist.
Last Thursday, Shkreli invoked his constitutional right against self-incrimination at a House Committee on Oversight and Government Reform hearing on drug pricing, and later tweeted that lawmakers in Congress were imbeciles.
He also faces separate federal securities fraud charges.

new Wu-Tang Clan album, Once Upon a Time in Shaolin.The Once Upon a Time in Shaolin album, which is the sole copy of that Shkreli bought for $2 million 

Shkreli achieved notoriety when his company, Turing Pharmaceuticals, bought the drug  ‘Daraprim, which is used to treat toxoplasmosis, a disease that can be fatal to H.I.V. patients. After buying the drug, Turing raised its price from less than twenty dollars per tablet to seven hundred and fifty dollars. This was too high, in the judgment of many people who knew the industry, and many more who did not. Experts called the increase “unjustifiable,” while those discussing the situation online used less measured language. Shkreli at first said he would lower the price, which scarcely mollified his critics. (One headline: “Martin Shkreli Lowers Drug Price, Is Still an Asshole.”) Then he said he wouldn’t, which increased the outrage—people were calling him “pharma bro,” the personification of a medical industry gone bad.’
A New York artist wants Shkreli to pay up for the $2 million Wu-Tang Clan album that contains his ripped off illustrations.  Jason Koza, said he never allowed his fan art to be used in packaging for the group’s ‘Once Upon a Time in Shaolin’

WuDisciples 1Koza said he thought his nine works would appear only on the website and that he never granted a license for his works to be copied or displayed anywhere else 

Koza, 34, filed a complaint on Tuesday that said he never allowed his fan art depicting Wu-Tang members to be used in packaging for the hip-hop group’s album, Once Upon a Time in Shaolin, the sole copy of which Shkreli bought.
Koza, said he never allowed his fan art to be used in packaging for the group’s ‘Once Upon a Time in Shaolin’ . Koza also blames Wu-Tang leader Robert ‘RZA’ Diggs for including the art in the album.
The former drug executive, Shkreli has bragged that he had no plans to listen to the album, but bought it to ‘keep it from the people.’
Koza said Cilvaringz has acknowledged the infringement, asking in a Jan. 31 email ‘if you want to skype discussing the use of your drawings. Thanks bro.’

Wu-tang Clan 1.pngThe Wu-Tang Clan is an American hip-hop group from New York City, originally composed of East Coast rappers RZA, GZA, Method Man, Raekwon, Ghostface Killah, Inspectah Deck, U-God, Masta Killa and Ol’ Dirty Bastard. The groups best-selling albums were Enter the Wu-Tang and Wu-Tang Forever

Koza is seeking unspecified damages plus profits stemming from copyright infringement. His lawyer said in a phone interview that Shkreli ‘didn’t need to know’ the illustrations were protected to be liable. ‘There is no intent requirement for copyright infringement,’ he said.

1 Trackback / Pingback

  1. Hedge Fund manager and biotech CEO, ‘Pharma Bro’ Martin Shkreli, sentenced to seven years for defrauding investors – KonnieMoments

Leave a Reply

%d bloggers like this: